News | May 09, 2007

Cedara, Varian Pen Licensing Agreement

May 10, 2007 - Cedara Software, a Merge Healthcare company, announced it has concluded a licensing agreement with Varian Medical Systems, giving Varian exclusive global rights to distribute Cedara’s I-Response technology within the radiation and medical oncology market.
Cedara I-Response is a tool that analyzes how cancerous tumors are responding to treatment. I-Response supports multiple imaging modalities and features patented analysis of fDM (Functional Diffusion Mapping) MR images. It allows professionals to visualize and quantify changes in tumor tissue resulting from cellular and metabolic mechanisms, and then track the data over time. In this way, Cedara I-Response has the potential to precisely monitor the impact of anti-cancer drugs and radiation therapy early in the course of treatment, adding to the information that clinicians can reference when developing personalized treatment plans.
Cedara I-Response complements Varian’s Dynamic Adaptive Radiation Therapy (DART) program with its image analysis capabilities that assist oncologists in making treatment decisions for their patients. Cedara I-Response has received FDA 510k clearance and the company expects a commercial release in June 2007.

Related Content

Sponsored Content | Videos | Business | July 28, 2017
Angelic McDonald, MSRS, CRA, FAHRA, regional director of imaging, Baylor Scott & White Health and the president-e
CareSelect Declared Fully Qualified Clinical Decision Support Mechanism by CMS
News | Clinical Decision Support | July 18, 2017
National Decision Support Company announced the full qualification of its CareSelect Platform as a Qualified Clinical...
CMS Proposes Delaying Clinical Decision Support Documentation to 2019
News | Clinical Decision Support | July 14, 2017 | Jeff Zagoudis, Associate Editor
In a series of proposed rule changes to the Medicare Physician Fee Schedule (MPFS) released July 13, the Centers for...
News | Artificial Intelligence | July 07, 2017
July 7, 2017 — Zebra Medical Vision and Telerad Tech, the technology arm of Teleradiology Solutions (TRS), announced
ACR Launches Updated LI-RADS for Liver Imaging
News | Clinical Decision Support | July 06, 2017
July 6, 2017 — Radiologists can improve their consistency of interpreting and reporting...
Sponsored Content | Videos | Clinical Decision Support | June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Fujitsu Develops AI-Based Technology to Retrieve Similar Disease Cases in CT Inspections

Newly developed technology to retrieve similar cases. Image courtesy of Fujitsu.

News | Artificial Intelligence | June 26, 2017
Fujitsu Laboratories Ltd. announced development of a technology to retrieve similar disease cases from a computed...
Siemens Healthineers and Fraunhofer MEVIS Announce Research Alliance on Clinical Decision Support
News | Clinical Decision Support | May 31, 2017
Siemens Healthineers and the Fraunhofer Institute for Medical Image Computing MEVIS announced the formation of a new...
ACR Highlights Initial Results of R-SCAN Program at 2017 Annual Meeting
News | Clinical Decision Support | May 22, 2017
The American College of Radiology (ACR) announced a series of sessions at the 2017 Annual Meeting that will highlight...
Partners HealthCare and GE Healthcare Launch 10-Year Collaboration on Artificial Intelligence
News | Artificial Intelligence | May 17, 2017
Partners HealthCare and GE Healthcare announced a 10-year collaboration to rapidly develop, validate and strategically...
Overlay Init